News - Global, Healthcare

Filter

Current filters:

GlobalHealthcare

Popular Filters

1 to 25 of 38 results

ICBA adopts antimicrobial resistance as an inaugural priority, proposed by BIA

ICBA adopts antimicrobial resistance as an inaugural priority, proposed by BIA

27-06-2014

At the inaugural meeting of the newly formed International Council of Biotech Associations (ICBA) which…

Antibiotics and Infectious diseasesBiotechnologyGlobalHealthcareResearch

New report calls on governments to implement national policies on hepatitis C

New report calls on governments to implement national policies on hepatitis C

25-06-2014

A report published by The Economist Intelligence Unit (EIU) has revealed that many countries around the…

Anti-viralsGlobalHealthcareJanssenPharmaceutical

Antibiotic crisis needs united global response, say UK experts

12-05-2014

Growing resistance to antibiotics and other drugs demands a coordinated global response on the same scale…

Antibiotics and Infectious diseasesGlobalHealthcarePharmaceuticalResearch

Antibiotic resistance is a serious public health threat according to WHO global report

Antibiotic resistance is a serious public health threat according to WHO global report

01-05-2014

Resistance of antibiotics is a serious threat happening now around the world, according to The World…

Antibiotics and Infectious diseasesGlobalHealthcarePharmaceutical

Need for age-appropriate drug formulations for elderly; report

Need for age-appropriate drug formulations for elderly; report

09-04-2014

Despite the elderly being the fastest-growing segment of the global population, only a few of their treatments…

GlobalHealthcarePharmaceuticalResearch

Report: Innovative medicines could deliver increased benefits in middle-income countries

Report: Innovative medicines could deliver increased benefits in middle-income countries

29-01-2014

There is clear evidence that innovative medicines have delivered significant value by reducing healthcare…

GlobalHealthcarePharmaceutical

FT Pharma 2013: Panel discusses diversity needed in high-level positions

FT Pharma 2013: Panel discusses diversity needed in high-level positions

04-12-2013

A Twitter debate was sparked yesterday after the Financial Times Global Pharmaceutical & Biotechnology…

GlobalHealthcareInterviewsPharmaceuticalPolitics

Health spending down in a third of OECD nations, as governments cut budgets

21-11-2013

Total health spending has fallen in one of three Organization for Economic Cooperation and Development…

FinancialGlobalHealthcarePharmaceutical

MSF calls for urgent action on vaccines to save lives

MSF calls for urgent action on vaccines to save lives

29-10-2013

Humanitarian medical organization Medecins Sans Frontieres is calling for four key policy changes to…

GlobalHealthcarePharmaceuticalPoliticsPricingVaccines

H1N1 virus market to be worth $273 million by 2018

22-10-2013

The H1N1 vaccines market has been forecast to decline in value over the next five years, reaching a value…

BiotechnologyFinancialGlobalHealthcareVaccines

UNITAID helps accessing quality drugs at affordable prices

03-09-2013

At an interactive session with Indian pharmaceuticals and diagnostics industry leaders organized by the…

Asia-PacificGenericsGlobalHealthcarePharmaceuticalPricing

In wake of Tivicay approval, MSF asks, "when will people in developing countries have access?"

13-08-2013

As the US Food and Drug Administration approved the new HIV drug Tivicay (dolutegravir) late Monday (The…

Anti-viralsdolutegravirGlobalHealthcarePharmaceuticalPricingTivicayViiV Healthcare

UNITAID market power results in price cuts of up to 80% for HIV/AIDS, TB and malaria products

30-05-2013

UNITAID's approach to transform health product markets has delivered price reductions of up to 80% for…

Anti-viralsAntibiotics and Infectious diseasesGenericsGlobalHealthcarePharmaceuticalPricingTropical diseases

GlaxoSmithKline reveals new research on health care models in developing countries

17-05-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) and the International Center for Social Franchising (ICSF)…

GlaxoSmithKlineGlobalHealthcarePharmaceutical

Rx drugs bulk buying may save governments money but poses a risk for some patients, says Canadian think-tank

14-05-2013

Governments that opt for prescription drug bulk-purchasing agreements can save taxpayers money but at…

FinancialGlobalHealthcarePharmaceutical

More collaboration needed to raise vaccination rates in developing nations, says analyst

12-04-2013

More collaboration is needed between pharmaceuticals companies, public health organizations and governments…

GlobalHealthcarePharmaceuticalResearchVaccines

Need for global policy innovation to tackle the "Silent Pandemic" that is hepatitis C, says EIU report

16-01-2013

There is an urgent need for countries around the world to develop strategies to tackle head-on the growing…

Anti-viralsBiotechnologyGlobalHealthcareMarkets & MarketingPharmaceutical

Need for better coordinated global approaches to falsified medicines, new report finds

13-12-2012

Opportunities for a better coordinated international response to the threat of falsified, or counterfeit,…

GlobalHealthcareMarkets & MarketingPharmaceutical

Novo Nordisk's Ryzodeg passes regulatory hurdle in Japan; diabetes burden review

03-12-2012

Global insulin market leader Novo Nordisk (NOV: N) of Denmark revealed this morning that its Ryzodeg…

Asia-PacificDegludecDiabetesGlobalHealthcareNovo NordiskPharmaceuticalPricingRegulationRyzodegTresiba

Big Pharma doing more for access to medicine in developing countries than two years ago

28-11-2012

The latest Access to Medicine Index, which ranks the top 20 pharmaceutical companies on their efforts…

AstraZenecaBayerGlaxoSmithKlineGlobalHealthcareJohnson & JohnsonMerck KGaAPharmaceuticalPricingResearch

Pharma anti-counterfeiting technologies market to reach $1.2 billion in 2015

30-10-2012

The global market for pharmaceutical anti-counterfeiting technologies will reach a value of $1.2 billion…

GenericsGlobalHealthcareMarkets & MarketingPharmaceutical

Further initiatives from GlaxoSmithKline to help tackle global health challenges; TB deal with Aeras

12-10-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) yesterday announced new measures to further advance its commitment…

Antibiotics and Infectious diseasesGlaxoSmithKlineGlobalHealthcarePharmaceuticalResearchVaccines

1 to 25 of 38 results

Back to top